Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Ortho-McNeil to appeal patent ruling on Razadyne

Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced that it will appeal yesterday's decision by the U.S. District Court of Delaware, which ruled the patent for Razadyne (galantamine hydrobromide) is invalid.

28 Aug 2008

New sleep lab to benefit shift-workers

Two specialist laboratories opening night at the University of Sydney will shed light on the impact of sleep and circadian disruption in medical disorders and shift-workers, and the neurobiological mechanisms underlying substance abuse and depression.

21 Aug 2008

New therapeutic approaches to protect neurons from inflammation and toxicity-induced neurodegeneration

New research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, provides evidence that one of the only naturally occurring fatty acids in the brain that has the ability to interact with the receptors originally identified as the targets of THC (the psychoactive component of marijuana) can help to protect brain cells from neurodegenerative diseases like Alzheimer's and Parkinson's.

20 Aug 2008

Addiction drug Vigabatrin proves successful in animal weight loss study

Vigabatrin, a medication proposed as a potential treatment for drug addiction by scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, also leads to rapid weight loss and reduced food intake according to a new animal study from the same research group.

20 Aug 2008

When the patient can't make the decision

Family members are often called upon to make medical choices for patients who are unable to do so themselves. Researchers led by Alexia Torke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc., studied how physicians treating these patients interacted with surrogate decision-makers.

18 Aug 2008

First drug for Huntington's disease approved for use in the U.S.

Huntington's disease is a fatal, inherited neurodegenerative disorder for which there is no cure and usually affects people in their 30s and 40s, but some patients are affected as early as childhood, while others aren't affected until they are older.

18 Aug 2008

Study looks at physician perspectives on surrogate decision making

18 Aug 2008

FDA approves tetrabenazine for Huntington's disease

The U.S. Food and Drug Administration has approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease.

17 Aug 2008

URMC & NIH partner to expand, accelerate clinical research in neurological diseases

The University of Rochester Medical Center (URMC) and the National Institute of Neurological Disorders and Stroke are hosting a week-long training session designed to create a new generation of researchers with the specialized skills necessary to conduct clinical trials in neurological disorders.

14 Aug 2008

Seattle Post-Intelligencer examines efforts to improve medication management for HIV-positive people

The Seattle Post-Intelligencer on Monday examined efforts by some organizations and pharmacies in the city and surrounding area to improve medication management for HIV-positive people.

13 Aug 2008

Robot controlled by biological brain provides insights into how the brain works

A multidisciplinary team at the University of Reading has developed a robot which is controlled by a biological brain formed from cultured neurons. This cutting edge research is the first step to examine how memories manifest themselves in the brain, and how a brain stores specific pieces of data.

13 Aug 2008

Study finds caregivers of spouses with dementia report sadness and loneliness

Spouses of husbands and wives with dementia pay an emotional toll as they care for their ailing spouse. This has prompted a call for new interventions and strategies to assist caregivers in coping with the demands of this difficult time, according to a study from Case Western Reserve University's Mandel School of Applied Social Sciences.

12 Aug 2008

Adalat XL Plus approved in Canada

Bayer Inc. announced that Health Canada has granted a Notice of Compliance (NOC) for Adalat XL Plus, a co-packaging of Adalat XL and Aspirin 81mg.

12 Aug 2008

PET scans spot signs of early Alzheimer's

Scientists in Finland say a type of imaging technique known as positron emission tomography (PET) scanning may be a useful and non-invasive way of diagnosing the early stages of Alzheimer’s disease.

11 Aug 2008

Subtle signs of Alzheimer's appear many years before symptoms appear

Scientists from the University of South Florida and the University of Kentucky report that people who develop Alzheimer's disease may show signs of this illness many decades earlier in life, including compromised educational achievement.

11 Aug 2008

Therapies which boost the clearance of faulty proteins in cells may slow down ageing

Scientists say as people age, their cells become less efficient at getting rid of damaged protein and the result is a buildup of toxic material; this is particularly apparent in Alzheimer's, Parkinson's disease and other neurodegenerative disorders associated with ageing.

11 Aug 2008